Cited by 55Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesSexual Differentiation and DisordersGrowth Hormone and Insulin-like Growth Factors

Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use

Open access
Sas, T.C.J., Gault, E.J., Zeger Bardsley, M., Menke, L.A., Freriks, K., Perry, R.J., Otten, B.J., de Muinck Keizer-Schrama, S.M.P.F. +4 more·2014·Hormone Research in Paediatrics

Abstract

There has been no consensus regarding the efficacy and safety of oxandrolone (Ox) in addition to growth hormone (GH) in girls with Turner syndrome (TS), the optimal age of starting this treatment, or the optimal dose. This collaborative venture between Dutch, UK and US centers is intended to give a summary of the data from three recently published randomized, placebo-controlled, double-blind studies on the effects of Ox. The published papers from these studies were reviewed within the group of authors to reach consensus about the recommendations. The addition of Ox to GH treatment leads to an increase in adult height, on average 2.3–4.6 cm. If Ox dosages<0.06 mg/kg/day are used, side effects are modest. The most relevant safety concerns are virilization(including clitoromegaly and voice deepening) and a transient delay of breast development. We advise monitoring signs of virilization breast development and possibly blood lipids during Ox treatment, in addition to regular follow-up assessments for TS. In girls with TS who are severely short for age, in whom very short adult stature is anticipated,or in whom the growth rate is modest despite good compliance with GH, adjunctive treatment with Ox at a dosage of 0.03–0.05 mg/kg/day starting from the age of 8–10 years onward scan be considered.

Integrity signals

Registry

Crossref · 10.1159/000358195

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sas, T. C. J., Gault, E. J., Zeger Bardsley, M., Menke, L. A., Freriks, K., Perry, R. J., Otten, B. J., de Muinck Keizer-Schrama, S. M. P. F., Timmers, H., Wit, J. M., Ross, J. L., & Donaldson, M. D. C.
Affiliations
  • Albert Schweitzer Ziekenhuis (NL)
  • Royal Hospital for Children (GB)
  • Leiden University Medical Center (NL)
  • Radboud University Medical Center (NL)
  • Thomas Jefferson University (US)
Venue
Hormone Research in Paediatrics
Publisher
S. Karger AG
Published
2014
Volume
81
Issue
5
Pages
289-297
ISSN
  • 1663-2818 (ISSN-L)
  • 1663-2826
OpenAlex
W2102501531
Cited by
55
References
24
Citations by year
2026: 1 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 2 · 2021: 8 · 2020: 4 · 2019: 10 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 9
FWCI
3.71
Type
journal article
Language
en
Open access
Locations
  • Hormone Research in Paediatrics (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
oxandrolone, Turner syndrome, growth hormone therapy, adult height, masculinization, clitoromegaly, breast development, treatment safety, treatment efficacy, dose recommendations, treatment timing, short stature, serum lipids
MeSH terms
Adolescent, Adult, Age Factors, Androgens, Child, Child, Preschool, Double-Blind Method, Female, Humans, Oxandrolone, Turner Syndrome, Randomized Controlled Trials as Topic, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review